- Division of Basic and Integrative Biological Sciences – DBIB
- Review Branch:
- Macromolecular Biophysics and Biological Chemistry – MBBC
- Study Section:
- Synthetic and Biological Chemistry A – SBCA
Dr. Anita Szajek received her Ph.D. in bioinorganic chemistry from University of Wisconsin in Madison, and she did postdoctoral work at Parke-Davis Pharmaceuticals and NIH National Cancer Institute on matrix metalloproteinases. She then joined Emergent BioSolutions as a scientist working to develop diagnostics, vaccines and pharmaceuticals for chronic bacterial infections and infectious diseases. She subsequently joined Human Genome Sciences as a senior scientist focused on purification process development activities, scale-up and analytical assay development from preclinical to Phase III. Dr. Szajek next moved to United States Pharmacopeia, where she served as a principal scientific liaison for over 10 years. She worked closely with FDA and WHO to develop public standards for heparins, blood products, proteins and synthetic peptides.